Can IVIG help premature Babies' lungs? new trial investigates
NCT ID NCT07561125
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether intravenous immunoglobulin (IVIG) can help treat bronchopulmonary dysplasia (BPD), a serious lung condition, in premature infants born at 28 weeks or earlier. The study will give IVIG to 29 babies and track their breathing support needs and lung health over time. The goal is to see if IVIG reduces the severity of BPD and improves long-term outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intravenous immunoglobulin (IVIG)
What this could lead to
If it works, this could point toward a treatment to reduce lung damage and improve breathing in very premature infants.
What could go wrong
This is a small, early-phase trial with only 29 participants, so results may not apply broadly. IVIG can cause side effects like allergic reactions or infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
International Peace Maternity and Child Health Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••